These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 27084133)

  • 21. Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.
    Toback SL; Levin MJ; Block SL; Belshe RB; Ambrose CS; Falloon J
    Expert Rev Vaccines; 2012 Nov; 11(11):1293-303. PubMed ID: 23151111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunisation against influenza.
    Commun Dis Rep CDR Wkly; 1994 Jul; 4(29):135. PubMed ID: 7522813
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma.
    Hahn M; Schnitzler P; Schweiger B; Kunz C; Ho AD; Goldschmidt H; Schmitt M
    Haematologica; 2015 Jul; 100(7):e285-8. PubMed ID: 25820335
    [No Abstract]   [Full Text] [Related]  

  • 24. Influenza and current guidelines for its control.
    Gall SA
    Infect Dis Obstet Gynecol; 2001; 9(4):193-5. PubMed ID: 11916174
    [No Abstract]   [Full Text] [Related]  

  • 25. Influenza vaccine--outmaneuvering antigenic shift and drift.
    Treanor J
    N Engl J Med; 2004 Jan; 350(3):218-20. PubMed ID: 14724300
    [No Abstract]   [Full Text] [Related]  

  • 26. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine.
    Myers CA; Faix DJ; Blair PJ
    Clin Infect Dis; 2011 Jul; 53(2):207-8. PubMed ID: 21690631
    [No Abstract]   [Full Text] [Related]  

  • 27. Influenza vaccination with 1/10th the full dose.
    Cooper CL; Davis H; Cameron DW
    N Engl J Med; 2004 Nov; 351(22):2339-40. PubMed ID: 15564552
    [No Abstract]   [Full Text] [Related]  

  • 28. Seasonal trivalent influenza vaccine for 2010-2011.
    Med Lett Drugs Ther; 2010 Oct; 52(1348):77-9. PubMed ID: 20885341
    [No Abstract]   [Full Text] [Related]  

  • 29. [The prophylactic efficacy of the trivalent polymer-subunit influenza vaccine Grippol (3)].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Pavlova LI; Malinovskiĭ AA
    Voen Med Zh; 1997 Feb; 318(2):47-9. PubMed ID: 9148581
    [No Abstract]   [Full Text] [Related]  

  • 30. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of influenza vaccines.
    Narayan KM; del Rio C
    N Engl J Med; 2010 Jan; 362(2):179-80; author reply 180-1. PubMed ID: 20071712
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative efficacy of influenza vaccines.
    Linder J
    N Engl J Med; 2010 Jan; 362(2):180; author reply 180-1. PubMed ID: 20077593
    [No Abstract]   [Full Text] [Related]  

  • 33. Influenza B viruses: not to be discounted.
    van de Sandt CE; Bodewes R; Rimmelzwaan GF; de Vries RD
    Future Microbiol; 2015; 10(9):1447-65. PubMed ID: 26357957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Seroconversion after vaccine with trivalent influenza vaccine during the epidemic season 1990/1 in Poland].
    Brydak L; Rudnicka H; Gut W; Magdzik W; Kańtoch M
    Przegl Epidemiol; 1992; 46(3):221-9. PubMed ID: 1296247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
    Voeten JT; Kiseleva IV; Glansbeek HL; Basten SM; Drieszen-van der Cruijsen SK; Rudenko LG; van den Bosch H; Heldens JG
    Arch Virol; 2010 Sep; 155(9):1391-9. PubMed ID: 20532926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preventive influenza vaccination].
    Glathe H
    Z Arztl Fortbild (Jena); 1990; 84(8):377-80. PubMed ID: 2378120
    [No Abstract]   [Full Text] [Related]  

  • 37. Fluarix quadrivalent vaccine for influenza.
    Graaf Hd; Faust SN
    Expert Rev Vaccines; 2015; 14(8):1055-63. PubMed ID: 26098443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influenza A Beijing is approaching. 2 new strains in this season's vaccine].
    Grandien M; Linde A
    Lakartidningen; 1993 Nov; 90(44):3881-3. PubMed ID: 8231547
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccine production: potential engineering approaches to pandemic influenza.
    Harding CV; Heuer AH
    J Pharm Sci; 2007 Nov; 96(11):2879-85. PubMed ID: 17721947
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
    Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.